What are the best routes to market in Remote Patient Monitoring?

A survey (link) from 2020 suggested that 55 to 58% of the European physicians believe that Remote Patient Monitoring (RPM) will play a key role in the future of care. But in order to successfully gain adoption, RPM companies need to figure out what is the most sustainable and scalable route to market. A lot of RPM companies have chosen pharma partnerships as their primary route to market, but is pharma the safest and most efficient option? Employer, payer and provider partnerships might be better and faster options for some companies. What are the commercialization models that will stick in the RPM industry? How does the therapeutic area determine the ideal route to market? In this meeting we will deep dive into the different commercialization models and how they determine the success of a RPM service.